The side effects of the COVID-19 pandemic on key public health elements - How the global emergency has changed the acute management of myocardial infarction and stroke, the network of cancer care, and assistance to frail individuals

Submitted: 8 January 2021
Accepted: 23 February 2021
Published: 24 September 2021
Abstract Views: 1228
PDF: 523
HTML: 8
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

The coronavirus disease 2019 (COVID-19) pandemic is a primary health problem globally. In particular, it has caused troubles even to the advanced health systems of Western countrieswho attempted to limit the spread of the infection and manage patients with severe respiratory distress. However, this sudden contingency has had a much higher cost if we also consider the cost of suspending ordinary clinical care or delays in the emergency pathways of non-COVID-19 patients. Furthermore, the policies applied to contain the contagion have exacerbated the socio-economic disparities of the population and isolated fragile patients, making them subject to clinical relapses or aggravation of chronic diseases. For this reason, the various specialist centers have equipped themselves to guarantee an effective therapeutic path. In this brief review, we have outlined some consequent repercussions on the management of acute and chronic cardiovascular and neurovascular diseases and on oncological treatment. In particular, we have described the effects of the current health reorganization on some acute and time-dependent diseases, such as stroke and acute coronary syndromes, in which therapeutic delay is potentially disabling or fatal. Furthermore, we have focused on cancer treatments, whose essential cornerstones are early screening and follow-up. Finally, the suffering of the local health network has led to a lack of continuity of care in fragile patients, such as psychiatric, marginalized, or multiple comorbid patients.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

PlumX Metrics

PlumX Metrics  provide insights into the ways people interact with individual pieces of research output (articles, conference proceedings, book chapters, and many more) in the online environment. Examples include, when research is mentioned in the news or is tweeted about. Collectively known as PlumX Metrics, these metrics are divided into five categories to help make sense of the huge amounts of data involved and to enable analysis by comparing like with like.

Citations

Worldometers.info.2020. COVID-19 coronavirus pandemic. Available from: https://www.worldometers.info/coronavirus/
Cossarizza A, De Biasi S, Guaraldi G, et al. COVID-19 working, SARS-CoV-2, the virus that causes COVID-19: cytometry and the new challenge for global health. Cytometry A 2020 [Epub ahead of print]. DOI: https://doi.org/10.1002/cyto.a.24002
European Centre for Disease Prevention and Control (ECDC). Considerations relating to social distancing measures in response to COVID-19 - Second update. ECDC; Stockholm: 2020.
Xiao H, Zhang Y, Kong D, et al. Social capital and sleep quality in individuals who self-isolated for 14 days during the coronavirus disease 2019 (COVID-19) outbreak in January 2020 in China. Med Sci Monit 2020;26 [Epub ahead of print]. DOI: https://doi.org/10.12659/MSM.923921
Cornwall W. Can you put a price on COVID-19 options? Experts weigh lives versus economics. Science 2020. [Epub ahead of print]. DOI: https://doi.org/10.1126/science.abb9969
Tsai WM. COVID-19: a potential public health problem for homeless populations. Lancet Public Health 2020 [Epub ahead of print]. DOI: https://doi.org/10.1016/S2468-2667(20)30053-0
Kinner SA, Young JT, Snow K, et al. Prisons and custodial settings are part of a comprehensive response to COVID-19. Lancet Public Health 2020 [Epub ahead of print]. DOI: https://doi.org/10.1016/S2468-2667(20)30058-X
Daniels JP. Venezuelan migrants ‘struggling to survive’ amid COVID-19. Lancet 2020;395:1023. DOI: https://doi.org/10.1016/S0140-6736(20)30718-2
Yang Y, Li W, Zhang Q, et al. Mental health services for older adults in China during the COVID-19 outbreak. Lancet Psychiatry 2020;7 [Epub ahead of print]. DOI: https://doi.org/10.1016/S2215-0366(20)30079-1
Kuwahara KK, Fukuda Y. COVID-19: Active measures to support community-dwelling older adults. Travel Med Infect Dis 2020 [Epub ahead of print].. DOI: https://doi.org/10.1016/j.tmaid.2020.101638
Bojdani E, Rajagopalan A, Chen A, et al. COVID-19 Pandemic: Impact on psychiatric care in the United States. Psychiatry Res 2020;289:113069. [Epub ahead of print]. DOI: https://doi.org/10.1016/j.psychres.2020.113069
Cui LB, Wang XH, Wang HN. Challenges facing coronavirus disease 2019: Psychiatric services for patients with mental disorders. Psychiatry Clin Neurosci 2020 [Epub ahead of print]. DOI: https://doi.org/10.1111/pcn.13003
Percudani M, Corradin M, Moreno M, et al. Mental health services in Lombardy during COVID-19 outbreak. Psychiatry Res 2020;288 [Epub ahead of print]. DOI: https://doi.org/10.1016/j.psychres.2020.112980
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin 2018;68:394-424. DOI: https://doi.org/10.3322/caac.21492
Ward EM, Sherman RL, Henley SJ, et al. Annual report to the nation on the status of cancer, featuring cancer in men and women age 20-49 years. J Nat Cancer Instit 2019;111:1279-97. DOI: https://doi.org/10.1093/jnci/djz106
Zhang L, Zhu F, Xie L, et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Ann Oncol 2020;31:894-901. DOI: https://doi.org/10.1016/j.annonc.2020.03.296
World Health Organization. Report of the WHO-China Joint Mission on coronavirus disease 2019 (COVID-19). Significant account of fatality rates and comorbidities in reports from China related to COVID-19 infection. Geneva: WHO; 2020.
The Lancet Oncology. COVID-19: global consequences for oncology. Lancet Oncol 2020;21:467. DOI: https://doi.org/10.1016/S1470-2045(20)30175-3
Asokan I, Rabadia SV, Yang EH. The COVID-19 pandemic and its impact on the cardio-oncology population. Curr Oncol Rep 2020;22:60. DOI: https://doi.org/10.1007/s11912-020-00945-4
Baud D, Qi X, Nielsen-Saines K, et al. Real estimates of mortality following COVID-19 infection. Lancet Infect Dis 2020 [Epub ahead of print]. DOI: https://doi.org/10.1016/S1473-3099(20)30195-X
Rusthoven CG, Yamamoto M, Bernhardt D, et al. Evaluation of first-line radiosurgery vs whole-brain radiotherapy for small cell lung cancer brain metastases: the FIRE-SCLC cohort study. JAMA Oncol 2020;6:1028-37. DOI: https://doi.org/10.1001/jamaoncol.2020.1271
Hellewell J, Abbott S, Gimma A, et al. Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts. Lancet Glob Health 2020;8:e488-96. DOI: https://doi.org/10.1016/S2214-109X(20)30074-7
Onesti CE, Rugo HS, Generali D, et al. Oncological care organisation during COVID-19 outbreak. ESMO Open 2020;5:e000853. DOI: https://doi.org/10.1136/esmoopen-2020-000853
Burki TK. Cancer guidelines during the COVID-19 pandemic. Lancet Oncol 2020;21:629-30. DOI: https://doi.org/10.1016/S1470-2045(20)30217-5
Gomez SL, Canchola AJ, Nelson DO, et al. Recent declines in cancer incidence: related to the Great Recession? Cancer Causes Control 2017;28:145-54. DOI: https://doi.org/10.1007/s10552-016-0846-y
Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054-62. DOI: https://doi.org/10.1016/S0140-6736(20)30566-3
Shi S, Qin M, Shen B, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol 2020 Mar 25. [Epub ahead of print]. DOI: https://doi.org/10.1001/jamacardio.2020.0950
Guo T, Fan Y, Chen M, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020 Mar 27. [Epub ahead of print]. DOI: https://doi.org/10.1001/jamacardio.2020.1017
Everaert BR, Muylle J, Twickler TB. Emerging cardiological issues during the COVID-19 pandemic. Eur J Clin Invest 2020;50:e13270. DOI: https://doi.org/10.1111/eci.13270
Wood S. The mystery of the missing STEMIs during the COVID-19 pandemic. tctMD. April 2, 2020. Availble from: https://www.tctmd.com/news/mystery-missing-stemis-during-covid-19-pandemic Accessed: April 3, 2020.
Piccolo R, Bruzzese D, Mauro C, et al. Population trends in rates of percutaneous coronary revascularization for acute coronary syndromes associated with the COVID-19 Outbreak. Circulation 2020;141:2035-7. DOI: https://doi.org/10.1161/CIRCULATIONAHA.120.047457
Vacanti G, Bramlage P, Schymik G, et al. Reduced rate of admissions for acute coronary syndromes during the COVID-19 pandemic: an observational analysis from a tertiary hospital in Germany. Observational Study Herz 2020;45:663-7. DOI: https://doi.org/10.1007/s00059-020-04991-3
De Rosa S, Spaccarotella C, Basso C, et al.; Società Italiana di Cardiologia and the CCU Academy investigators group. Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era. Eur Heart J 2020;41:2083-8. DOI: https://doi.org/10.1093/eurheartj/ehaa409
Böhm M, Frey N, Giannitsis E, et al. Coronavirus disease 2019 (COVID-19) and its implications for cardiovascular care: expert document from the German Cardiac Society and the World Heart Federation. Clin Res Cardiol 2020;109:1446-59. DOI: https://doi.org/10.1007/s00392-020-01656-3
Katz JN, Sinha SS, Alviar CL, et al. COVID-19 and disruptive modifications to cardiac critical care delivery: JACC review topic of the week. J Am Coll Cardiol 2020;76:72-84. DOI: https://doi.org/10.1016/j.jacc.2020.04.029
Scholz KH, Maier SKG, Maier LS, et al. Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial. Eur Heart J 2018;39:1065-74. DOI: https://doi.org/10.1093/eurheartj/ehy004
Zhang B, Shen DP, Zhou XC, et al. Long-term prognosis of patients with acute non-ST-segment elevation myocardial infarction undergoing different treatment strategies. Chin Med J (Engl) 2015;128:1026-31. DOI: https://doi.org/10.4103/0366-6999.155071
Kristoffersen ES, Jahr SH, Thommessen B, Rønning OM. Effect of COVID-19 pandemic on stroke admission rates in a Norwegian population. Acta Neurol Scand 2020;142:632-6. DOI: https://doi.org/10.1111/ane.13307
Lecouturier J, Murtagh MJ, Thomson RG, et al. Response to symptoms of stroke in the UK: a systematic review. BMC Health Serv Res 2010;10:157. DOI: https://doi.org/10.1186/1472-6963-10-157
Teuschl Y, Brainin M. Stroke education: discrepancies among factors influencing prehospital delay and stroke knowledge. Int J Stroke 2010;5:187â€208. DOI: https://doi.org/10.1111/j.1747-4949.2010.00428.x
Le Bonniec A, Haesebaert J, Derex L, et al. Why patients delay their first contact with health services after stroke? A qualitative focus groupâ€based study. PLoS One 2016;11:e0156933. DOI: https://doi.org/10.1371/journal.pone.0156933
Faiz KW, Sundseth A, Thommessen B, et al. Factors related to decision delay in acute stroke. J Stroke Cerebrovasc Dis 2014;23:534â€9. DOI: https://doi.org/10.1016/j.jstrokecerebrovasdis.2013.05.007
Jorgensen HS, Nakayama H, Reith J, et al. Factors delaying hospital admission in acute stroke: the Copenhagen Stroke Study. Neurology 1996;47:383â€7. DOI: https://doi.org/10.1212/WNL.47.2.383
Wester P, RÃ¥dberg J, Lundgren B, et al. Factors associated with delayed admission to hospital and inâ€hospital delays in acute stroke and TIA: a prospective, multicenter study. Seek†Medicalâ€Attentionâ€inâ€Time Study Group. Stroke 1999;30:40â€8. DOI: https://doi.org/10.1161/01.STR.30.1.40
Bersano A, Kraemer M, Touzé E, et al. Stroke care during the COVID-19 pandemic: experience from three large European countries. Eur J Neurol 2020;27:1794-800. DOI: https://doi.org/10.1111/ene.14375
Bersano A, Pantoni L. On being a neurologist in Italy at the time of the COVID-19 outbreak. Neurology 2020 [In press]. DOI: https://doi.org/10.1212/WNL.0000000000009508
Baracchini C, Pieroni A, Viaro F, et al. Acute stroke management pathway during coronavirus-19 pandemic. Neurol Sci 2020 [Epub ahead of print]. DOI: https://doi.org/10.1007/s10072-020-04375-9
Caso V, Federico A. No lockdown for neurological diseases during COVID-19 pandemic infection. Neurol Sci 2020 [Epub ahead of print]. DOI: https://doi.org/10.1007/s10072-020-04389-3
Stefanini GG, Azzolini E, Condorelli G. Critical organizational issues for cardiologists in the COVID-19 Outbreak: a frontline experience from Milan, Italy. Circulation 2020 [Epub ahead of print]. DOI: https://doi.org/10.1161/CIRCULATIONAHA.120.047070
Silvestrelli G, Parnetti L, Paciaroni M, et al. Early admission to stroke unit influences clinical outcome. Eur J Neurol 2006;3:250â€5. DOI: https://doi.org/10.1111/j.1468-1331.2006.01187.x
Lees KR, Bluhmki E, von Kummer R, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010;375:1695â€703. DOI: https://doi.org/10.1016/S0140-6736(10)60491-6

How to Cite

Cioni, G., & Canini, J. (2021). The side effects of the COVID-19 pandemic on key public health elements - How the global emergency has changed the acute management of myocardial infarction and stroke, the network of cancer care, and assistance to frail individuals. Italian Journal of Medicine, 15(3). https://doi.org/10.4081/itjm.2021.1462